Hemispherx BioPharma, Inc. (AMEX:HEB)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Recs

0
Player Avatar marginaddict (< 20) Submitted: 6/22/2009 10:51:28 PM : Underperform Start Price: $2.13 HEB Score: +135.67

Snake oil.

Report this Post 1 Comment
Member Avatar cfsguy99 (26.18) Submitted: 7/22/2009 4:15:24 AM
Recs: 0

Ask someone who was in the drug trials for AMPLIGEN and benefitted from it, you might change your mind.

Featured Broker Partners


Advertisement